Agios Pharmaceuticals Profit Margin 2012-2019 | AGIO
Current and historical gross margin, operating margin and net profit margin for Agios Pharmaceuticals (AGIO) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Agios Pharmaceuticals net profit margin as of June 30, 2019 is -383.05%.
|Agios Pharmaceuticals Annual Profit Margins
|Agios Pharmaceuticals Quarterly Profit Margins
||Medical Products Manufacturing
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. It discovers and develops therapeutics in the field of cancer metabolism and inborn errors of metabolism. The Company's products include AG-221, AG-120, enzyme glutaminase and AG-348. Agios Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.